Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

177
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
177
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

160
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
160
Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

311
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
311
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

371
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
371
Renal Clearance01:23

Renal Clearance

1.4K
The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
1.4K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

58
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
58

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Web-Based Program to Facilitate Prescription of Twice-Weekly Hemodialysis.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Ergothioneine Depletion in Peritoneal Dialysis.

Kidney360·2025
Same author

Properties of uremic solutes that allow their effective control by peritoneal dialysis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2025
Same author

From niche to norm: a multiaction plan to close gaps and mainstream incremental hemodialysis.

Kidney international·2025
Same author

Economic Considerations of Incremental Hemodialysis.

Kidney360·2025
Same author

Can Intermittent Hemodialysis Normalize Plasma Solute Levels?

Kidney360·2025

Related Experiment Video

Updated: Sep 28, 2025

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.5K

Improving Clearance for Renal Replacement Therapy.

Seolhyun Lee1,2, Tammy L Sirich1,2, Timothy W Meyer1,2

  • 1Department of Medicine, Stanford University, Palo Alto, California.

Kidney360
|March 31, 2022
PubMed
Summary
This summary is machine-generated.

Current hemodialysis focuses on urea removal, but other solutes may cause illness. This review explores methods to enhance non-urea solute clearance, potentially improving patient health.

More Related Videos

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
09:43

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

Published on: August 10, 2015

16.1K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

7.6K

Related Experiment Videos

Last Updated: Sep 28, 2025

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.5K
Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
09:43

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

Published on: August 10, 2015

16.1K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

7.6K

Area of Science:

  • Nephrology
  • Renal Medicine
  • Uremic Toxin Research

Background:

  • Hemodialysis adequacy is primarily assessed by urea clearance, a metric nearing its maximum achievable level with current technology.
  • Residual uremic illness in hemodialysis patients may be linked to the inefficient removal of non-urea solutes.
  • Urea clearance alone may not fully represent the effectiveness of hemodialysis in managing patient health.

Purpose of the Study:

  • To review and discuss methods for improving the clearance of non-urea solutes during hemodialysis.
  • To highlight the potential benefits of enhanced non-urea solute removal for patients undergoing hemodialysis.
  • To identify areas for future clinical research in hemodialysis optimization.

Main Methods:

  • Literature review of existing and proposed methods for increasing solute clearance in hemodialysis.
  • Analysis of the contribution of various non-urea solutes to uremic toxicity.
  • Discussion of the limitations of current urea-based assessment of dialysis adequacy.

Main Results:

  • Current hemodialysis methods achieve high urea clearance, limiting further significant improvements.
  • Non-urea solutes, cleared less efficiently than urea, are implicated in ongoing patient morbidity.
  • Several strategies exist to potentially enhance the removal of these non-urea solutes.

Conclusions:

  • Optimizing hemodialysis may require focusing on the clearance of non-urea solutes beyond urea.
  • Enhanced removal of specific non-urea toxins could improve the health outcomes of patients on hemodialysis.
  • Further clinical investigation is essential to validate the impact of increased non-urea solute clearance on patient well-being.